Tuberc Respir Dis
TRD
Tuberculosis and Respiratory Diseases
1738-3536
2005-6184
The Korean Academy of Tuberculosis and Respiratory Diseases
10.4046/trd.2017.0101.r
Erratum
Erratum: Smoking Cessation Strategies Targeting Specific Populations
https://orcid.org/0000-0001-9616-2722
Chun
Eun Mi
M.D.
Ph.D.
Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, Ewha Womans University Mokdong Hospital, Ewha Womans University College of Medicine, Seoul, Korea.
04
2019
28
02
2019
82
2
178
178
Copyright©2019. The Korean Academy of Tuberculosis and Respiratory Diseases
2019
The Korean Academy of Tuberculosis and Respiratory Diseases
It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)
Smoking Cessation Strategies Targeting Specific Populations
Tuberc Respir Dis. 2019 Jan;82(1):1-5.
Published online Mar 7, 2018. https://doi.org/10.4046/trd.2017.0101
On page 3, “The control group of patients with no mental disorders showed no differences from other groups in the frequency of serious neuropsychiatric side effects, which were observed in 13 of the 99 subjects in the varenicline group (1.3%), 22 of the 989 subjects in the bupropion group (2.2%), 25 of the 1,006 subjects in the nicotine patch group (2.5%), and 24 of the 999 subjects in the placebo group (2.4%).“ should be corrected as follows:
The control group of patients with no mental disorders showed no differences from other groups in the frequency of serious neuropsychiatric side effects, which were observed in 13 of the 990 subjects in the varenicline group (1.3%), 22 of the 989 subjects in the bupropion group (2.2%), 25 of the 1,006 subjects in the nicotine patch group (2.5%), and 24 of the 999 subjects in the placebo group (2.4%).